InsidersTradesSigma
Explore the detailed record of transactions filed by Scalzo Richard William, Autre. Director active across 1 companies, notably Dyne Therapeutics, Inc.. Aggregated, 6 reports have been published. Total volume traded: €12k. The latest transaction was disclosed on 14 June 2022 — Disposition. Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Richard William Scalzo is a key member of Dyne Therapeutics, Inc. Although his specific role is not detailed, he contributes to the company's mission through his expertise and guidance. His commitment to innovation and strategic development is essential for Dyne Therapeutics' success.